At Scene, we meet patients where they are—every day—to build trusted relationships and empower lasting change.
People
Expert care,
human connection.
They’re experienced, motivational, and real. Our care team of highly qualified pharmacists, nurses, navigators, and coaches become advocates and confidants who can inspire positive behavior change.
Science
Evidence-based,
CDC recommended.
Our targeted, science-backed interventions include Comprehensive Medication Reviews, video Directly Observed Therapy, Linkage to Care, and more, all of which help patients address challenges, build new habits, and self-manage their conditions.
.png)
Technology
Accessible, 
easy to use for all.
We’ve been improving health equity in “hard-to-reach” groups for over 10 years. Our app works in low-connectivity areas, uses the patient’s own smartphone, supports 20+ languages, and uses messaging that’s easy to understand.
‍
Immediate and enduring value for organizations across the healthcare landscape.
Reduce EDÂ by 26% and IP by 17%1
Reduction is compared to the unengaged control group. It yielded cost savings up to $6,300 per engaged member per year for high utilizers.
Achieve 4.8/5 member satisfaction with 80 NPS
Our care team delivers unparalleled engagement with an average of 166 touch points per engaged member through async video and chat.
Improve clinical outcomes with a 1.8% reduction in HbA1c for members with A1c > 9
Clients see improved clinical measures across multiple conditions within 3 months. There's no faster way to improved outcomes & cost savings.
Impact 5+ quality metrics
We impact HEDIs & STARS measures related to diabetes, hypertension and asthma control. Disease manageemnt refill & prevention measures.
Reduce EDÂ by 26% and IP by 17%1
Reduction is compared to the unengaged control group. It yielded cost savings up to $6,300 per engaged member per year for high utilizers.
Achieve 4.8/5 member satisfaction with 80 NPS
Our care team delivers unparalleled engagement with an average of 166 touch points per engaged member through async video and chat.
Improve clinical outcomes with a 1.8% reduction in HbA1c for members with A1c > 9
Clients see improved clinical measures across multiple conditions within 3 months. There's no faster way to improved outcomes & cost savings.
Impact 5+ quality metrics
We impact HEDIs & STARS measures related to diabetes, hypertension and asthma control. Disease manageemnt refill & prevention measures.
Reduce EDÂ by 26% and IP by 17%1
Reduction is compared to the unengaged control group. It yielded cost savings up to $6,300 per engaged member per year for high utilizers.
Achieve 4.8/5 member satisfaction with 80 NPS
Our care team delivers unparalleled engagement with an average of 166 touch points per engaged member through async video and chat.
Improve clinical outcomes with a 1.8% reduction in HbA1c for members with A1c > 9
Clients see improved clinical measures across multiple conditions within 3 months. There's no faster way to improved outcomes & cost savings.
Impact 5+ quality metrics
We impact HEDIs & STARS measures related to diabetes, hypertension and asthma control. Disease manageemnt refill & prevention measures.
Reduce EDÂ by 26% and IP by 17%1
Reduction is compared to the unengaged control group. It yielded cost savings up to $6,300 per engaged member per year for high utilizers.
Achieve 4.8/5 member satisfaction with 80 NPS
Our care team delivers unparalleled engagement with an average of 166 touch points per engaged member through async video and chat.
Improve clinical outcomes with a 1.8% reduction in HbA1c for members with A1c > 9
Clients see improved clinical measures across multiple conditions within 3 months. There's no faster way to improved outcomes & cost savings.
Impact 5+ quality metrics
We impact HEDIs & STARS measures related to diabetes, hypertension and asthma control. Disease manageemnt refill & prevention measures.
Michael
Angelica
Perry
Empowering patients to take control of their condition and take their medication properly delivers unparalleled clinical outcomes.
In a majority Medicaid population, we helped pediatric members with asthma in West Baltimore reduce their inhaler error rate from 73% to 0% in 3 weeks and achieve an 80% adherence rate after 4 weeks.5
‍
We helped Medicaid members with an average A1C greater than 9 achieve an average decrease of 1.8 points.4
‍
In a Medicaid MCO population, we helped 72% of members with hypertension achieve self-monitored blood pressure readings within the controlled range.11
In patients with Sickle Cell Disease, video DOT for hydroxyurea resulted in observed adherence rates of 88%8 and improved median medication possession ratio (MPR) from 61.7% to 84.4%.9
Across numerous publications, patients have achieved treatment success rates as high as 96%12 and patient adherence rates consistently ranging from 90-100% with our program.2,12,13
We helped pediatric heart transplant recipients achieve a 90% average adherence rate with a 21.7% reduction in major late ventricular events (MLVI).10
In a pharmacist-led implementation of our program in Nevada, HIV patients achieved a 98% observed adherence rate to life-saving ART therapies.14
.png)
In a population of 85% Medicaid members with SUD in a methadone program, we helped participants achieve an 88.6% average observed adherence rate.7
In an SDOH-burdened, injection drug-using HCV population across 8 U.S. regions, our solution drove a 91% sustained virologic response (SVR) with an 84% average observed adherence rate.6
Backed by science
We have the most extensive catalog of peer-reviewed publications among medication adherence companies. Over 25 peer-reviewed publications show our technology-enabled service boosts true medication adherence, the fastest way to improve health.
MedEngagement uses
1:1 async video, chat, phone, email, and mail to deliver
‍personalized medication support at scale.
Video DOT
1:1 nurse-led medication support
Members participate in 60-90 days of daily asynchronous video and text communications with a nurse and receive personalized video coaching, education, and motivational content.
Outreach & education
Disease education and program awareness Members receive access to our care team and video-forward, condition-specific educational outreach via phone calls, emails, print materials, and text messages.
Linkage to Care
Care and resource navigation
Members complete crucial steps for medication adherence, such as seeing their providers, getting labs and vitals, getting prescriptions, and accessing health plan resources. This approach improves clinical outcomes, reduces costs, and enhances HEDIS metrics.
Medication Review
Members review their medication in app, where our care team can identify and resolve medication challenges. Our nurse & pharmacist can confirm proper administration, answer any questions about medication or technique. This includes extensive follow-up to ensure providers and members implement suggested medication changes.
Our 700+ customers spanning health plans, public health, life sciences, and more are transforming disease management.
.png)
10+ years of experience and numerous recognitions validate our approach.
.png)
.png)
References
- Improvement in utilization for an emerging and high risk population of members with diabetes. Analysis performed by a medical economics team of a large national Medicaid MCO. Cost savings & reduction in ED/IP visits represent impact on Scene engaged members compared to unengaged population.
- Morris, S., Miner, M., Rodriguez, T., Stancil, R., Wiltz-Beckham, D., & Chorba, T. (2017). Notes from the field: Tuberculosis control activities after Hurricane Harvey — Texas, 2017. MMWR Morbidity and Mortality Weekly Report, 66(49), 1362–1363. http://dx.doi.org/10.15585/mmwr.mm6649a5
- Holzman, S. B., Zenilman, A., & Shah, M. (2018). Advancing patient-centered care in tuberculosis management: A mixed-methods appraisal of video directly observed therapy. Open Forum Infectious Diseases, 5(4), ofy046. https://doi.org/10.1093/ofid/ofy046
- CareFirst data, needs a citation
- McIntire, K., Weis, B., Litwin Ye, L., & Krugman, S. D. (2022). Feasibility of video observed therapy to support controller inhaler use among children in West Baltimore. The Journal of asthma : official journal of the Association for the Care of Asthma, 59(10), 1961–1972. https://doi.org/10.1080/02770903.2021.1984525
- Litwin, A. H., Lum, P. J., Taylor, L. E., Mehta, S. H., Tsui, J. I., Feinberg, J., Kim, A. Y., Norton, B. L., Heo, M., Arnsten, J., Meissner, P., Karasz, A., Mckee, M. D., Ward, J. W., Johnson, N., Pericot-Valverde, I., Agyemang, L., Stein, E. S., Thomas, A., Borsuk, C., … HERO Study Group (2022). Patient-centred models of hepatitis C treatment for people who inject drugs: a multicentre, pragmatic randomised trial. The lancet. Gastroenterology & hepatology, 7(12), 1112–1127. https://doi.org/10.1016/S2468-1253(22)00275-8
- Hallgren, K. A., Darnton, J., Soth, S., Blalock, K. L., Michaels, A., Grekin, P., Saxon, A. J., Woolworth, S., & Tsui, J. I. (2022). Acceptability, feasibility, and outcomes of a clinical pilot program for video observation of methadone take-home dosing during the COVID-19 pandemic. Journal of substance abuse treatment, 143, 108896. https://doi.org/10.1016/j.jsat.2022.108896
- Creary, S., Chisolm, D., Stanek, J., et al. (2020). Measuring hydroxyurea adherence by pharmacy and laboratory data compared with video observation in children with sickle cell disease. Pediatric Blood & Cancer, 67, e28250. https://doi.org/10.1002/pbc.28250
- Creary, S., Chisolm, D., Stanek, J., Hankins, J., & O'Brien, S. H. (2019). A Multidimensional Electronic Hydroxyurea Adherence Intervention for Children With Sickle Cell Disease: Single-Arm Before-After Study. JMIR mHealth and uHealth, 7(8), e13452. https://doi.org/10.2196/13452
- Killian, M. O., Clifford, S., Lustria, M. L. A., Skivington, G. L., & Gupta, D. (2022). Directly observed therapy to promote medication adherence in adolescent heart transplant recipients. Pediatric transplantation, 26(5), e14288. https://doi.org/10.1111/petr.14288
- Scene Health. (2023). Case Study: Improving Hypertension Outcomes with a Medicaid Health Plan. Scene Health. Retrieved from https://insights.scene.health/hubfs/Scene%20Public/Case%20Studies/Health%20Plans/Scene%20-%20Health%20Plan%20Case%20Study%20-%20Hypertension.pdf
- Perry, A., Chitnis, A., Chin, A., Hoffmann, C., Chang, L., Robinson, M., Maltas, G., Munk, E., & Shah, M. (2021). Real-world implementation of video-observed therapy in an urban TB program in the United States. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 25(8), 655–661. https://doi.org/10.5588/ijtld.21.0170
- Holzman, S. B., Zenilman, A., & Shah, M. (2018). Advancing Patient-Centered Care in Tuberculosis Management: A Mixed-Methods Appraisal of Video Directly Observed Therapy. Open forum infectious diseases, 5(4), ofy046. https://doi.org/10.1093/ofid/ofy046
- Scene Health. (2022). Emocha Health Rx Healthy Living Flip The ScriptHIV Program Adherence Services Program Review. Scene Health.
‍